JNJ News Monday, November 16, 2026 +0.60 Positive

Johnson & Johnson Inks $2.2B Deal for Eye Drug Developer Ollin Biosciences

Johnson & Johnson Inks $2.2B Deal for Eye Drug Developer Ollin Biosciences

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed